|
Date |
Milestone |
Abstract |
|
2011-12 |
Became an approved partner of  Limited Taiwan |
Welmore became an approvel partner of Healthcare Sector.
The company's capital increased to NT$88 millions. |
|
2010-07 |
Invested in
Salutor Co., Ltd.
|
Salutor
became the sole distributor of 
products in Taiwan.
The
company's capital increased to NT$80 millions. |
|
2009-07 |
Welgene Biotech engage in
"aCGH applied in the examination of chromosome
aberrations" project |
Welgene Biotech engage in "aCGH applied in the
examination of chromosome aberrations" through Economy
Department plan of special subsidy.
The
company's capital increased to NT$75 millions. |
|
2008-10 |
Became sole
distributor of
 endoscopes in Taiwan.
|
 endoscope
business is integrated to
medical systems business
division on Oct. 1, 2008.
The
company's capital increased to NT$68 millions. |
|
2007-09 |
Invested in "gene chip application plan"
with
Welgene Biotech through Economy Department plan of special case |
Welmore and
Welgene Biotech invested in "gene chip
application plan-nucleic acids purification service medicament
development" through Economy Department plan of special case
subsidy.
The company's
capital increased to NT$60 millions. |
|
2007-05 |
Sole distributor of  products in Taiwan |
Welmore became the sole distributor
of products in Taiwan. |
|
2007-02 |
Welgene Biotech was
certified by  for Agilent Certified
Microarray Service Provider |
Welgene Biotech was certified by
for Agilent Certified Microarray Service Provider in Feb. 2007.
Welgene became one of the nine companies in the world, and also the first chip service company in Asia, certified by. |
|
2006-09 |
Welgene Biotech was accredited by Taiwan
Accreditation Foundation for ISO 17025 |
Welgene Biotech
was
accredited by Taiwan Accreditation Foundation for ISO 17025. It
provides high- quality total RNA purification service and
Microarray service. |
|
2006-6 |
Welgene
Biotech applied the accreditation |
Welgene Biotech
applied the accreditation
- ISO 17025 accreditation
- Certificate of Microarray service provider
Welmore increased the paid-in capital to NT$ 50 millions. |
|
2005-09 |
Became distributor of
products in Taiwan
|
is the first manufacturer of ICC system and APC system in the world.
Welmore became the distributor in thoracic internal medicine, digestive internal medicine and rectum surgical field. |
|
2005-09 |
Joined university and industry liaison project. |
Welgene Biotech joined the university and industry liaison project.
Raised the paid-in capital to NT$45.06 millions. |
|
2004-12 |
Set up Taichung and Kaohsiung branches |
Welmore set up branch office in Taichung and Kaohsiung.
Raised the paid-in capital to NT$38 millions. |
|
2004-08 |
Became sole distributor in Endoscope field |
is the subsidy of , Japan.
Welmore obtained the sole distributorship of Endoscopes in Taiwan.
|
|
2004-02 |
Invested in
Welgene Biotech Co., Ltd.
|
Welgene Biotech focuses on Microarray and Real-Time PCR service.
Raised the paid-in capital to NT$30 millions. |
|
2003-09 |
Moveed headquarters to NanKang Software Park |
Moved to NKSP for better industrial clustering effect.
|
|
2002-10 |
Started providing medical device sales & service business |
Started our business in distributing medical devices & services. Raised paid-in capital to NT$20 millions. |
| 2001-12 |
Established |
Welmore established with paid-in capital of NT$10 millions. |
